# FDA recall D-0094-2023

> **Camber Pharmaceuticals, Inc** · Class III · drug recall initiated 2022-12-06.

## Product

Lacosamide Oral Solution, USP, CV, 10mg/mL, packaged in 200 mL bottle, Rx Only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Manufactured By: HETERO LABS LIMITED, Jeedimetla, Hyderabad - 500 055, India, NDC 31722-627-26

## Reason for recall

Failed Excipient Specifications: out of specification result observed for p-Hydroxybenzoic Acid content

## Distribution

USA Nationwide

## Key facts

- **Recall number:** D-0094-2023
- **Recalling firm:** Camber Pharmaceuticals, Inc
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-12-06
- **Report date:** 2022-12-21
- **Termination date:** 2024-03-15

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Piscataway, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0094-2023

## Citation

> AI Analytics. FDA recall D-0094-2023. Retrieved 2026-06-24 from https://api.ai-analytics.org/recall/D-0094-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*